New registry tracks Post-Surgery combo therapy for rare head and neck cancer
NCT ID NCT06464198
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a registry that collects information from 100 people with advanced salivary gland cancer who receive radiation and chemotherapy together after surgery. The goal is to create a database to track how well the treatment works and its side effects. It is not testing a new drug but rather gathering real-world data to guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
simultaneous postoperative radiochemotherapy (radiation and chemotherapy given together after surgery)
What this could lead to
If successful, this registry could provide valuable data to help doctors understand how well this combined treatment works for advanced salivary gland cancer.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the treatment is better than alternatives. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SALIVARY GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erlangen, Universitätsklinikum Strahlenklinik
RECRUITINGErlangen, 91054, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••